The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
DeepCDR: a hybrid graph convolutional network for predicting cancer drug response
Open accessAbstract
Motivation: Accurate prediction of cancer drug response (CDR) is challenging due to the uncertainty of drug efficacy and heterogeneity of cancer patients. Strong evidences have implicated the high dependence of CDR on tumor genomic and transcriptomic profiles of individual patients. Precise identification of CDR is crucial in both guiding anti-cancer drug design and understanding cancer biology. Results: In this study, we present DeepCDR which integrates multi-omics profiles of cancer cells and explores intrinsic chemical structures of drugs for predicting CDR. Specifically, DeepCDR is a hybrid graph convolutional network consisting of a uniform graph convolutional network and multiple subnetworks. Unlike prior studies modeling hand-crafted features of drugs, DeepCDR automatically learns the latent representation of topological structures among atoms and bonds of drugs. Extensive experiments showed that DeepCDR outperformed state-of-the-art methods in both classification and regression settings under various data settings. We also evaluated the contribution of different types of omics profiles for assessing drug response. Furthermore, we provided an exploratory strategy for identifying potential cancer-associated genes concerning specific cancer types. Our results highlighted the predictive power of DeepCDR and its potential translational value in guiding disease-specific drug design. Availability and implementation: DeepCDR is freely available at https://github.com/kimmo1019/DeepCDR. Supplementary information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
(2014) · Cited by 33,419
Batch Normalization: Accelerating Deep Network Training by Reducing Internal Covariate Shift
Ioffe, S., & Szegedy, C. (2015) · arXiv · doi:10.48550/arxiv.1502.03167 · Cited by 27,818
Semi-supervised classification with graph convolutional networks
Kipf, T. N., & Welling, M. (2016) · arXiv · doi:10.48550/arxiv.1609.02907 · Cited by 24,853
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090
Self-citationGenerating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Deep reinforcement learning for de novo drug design
Popova, M., Isayev, O., & Tropsha, A. (2018) · Science Advances · doi:10.1126/sciadv.aap7885 · Cited by 1,182
Geeleher, P., Cox, N. J., & Huang, R. S. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r47 · Cited by 890
Molecular fingerprint similarity search in virtual screening
Cereto-Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcia-Vallvé, S., & Pujadas, G. (2015) · Methods · doi:10.1016/j.ymeth.2014.08.005 · Cited by 846
DNA Methylation in Cancer and Aging
Klutstein, M., Nejman, D., Greenfield, R., & Cedar, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3278 · Cited by 810
MOLI: multi-omics late integration with deep neural networks for drug response prediction
Sharifi-Noghabi, H., Zolotareva, O., Collins, C. C., & Ester, M. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz318 · Cited by 421
Objective-Reinforced Generative Adversarial Networks (ORGAN) for Sequence Generation Models
Guimaraes, G. L., Sánchez-Lengeling, B., Outeiral, C., Farias, P. L. C., & Aspuru‐Guzik, A. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1705.10843 · Cited by 413
Kantarjian, H. M., Giles, F. J., Bhalla, K. N., Pinilla-Ibarz, J., Larson, R. A., Gattermann, N., Ottmann, O. G., Hochhaus, A., Radich, J. P., Saglio, G., et al. (2011) · Blood · doi:10.1182/blood-2010-03-277152 · Cited by 380
Chang, Y., Park, H., Yang, H.-J., Lee, S., Lee, K.-Y., Kim, T. S., Jung, J., & Shin, J.-M. (2018) · Scientific Reports · doi:10.1038/s41598-018-27214-6 · Cited by 320
Modeling precision treatment of breast cancer
Daemen, A., Griffith, O. L., Heiser, L. M., Wang, N. J., Enache, O. M., Sanborn, Z., Pepin, F., Durinck, S., Korkola, J. E., Griffith, M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r110 · Cited by 295
Next-generation sequencing to guide cancer therapy
Gagan, J., & Van Allen, E. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0203-x · Cited by 280
A review of connectivity map and computational approaches in pharmacogenomics
Musa, A., Ghoraie, L. S., Zhang, S.-D., Galzko, G., Yli-Harja, O., Dehmer, M., Haibe-Kains, B., & Emmert-Streib, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw112 · Cited by 260
Predicting Anticancer Drug Responses Using a Dual-Layer Integrated Cell Line-Drug Network Model
Zhang, N., Wang, H., Fang, Y., Wang, J., Zheng, X., & Liu, X. S. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004498 · Cited by 209
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Lee, J.-K., Liu, Z., Sa, J. K., Shin, S., Wang, J., Bordyuh, M., Cho, H. J., Elliott, O., Chu, T., Choi, S. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0209-6 · Cited by 203
Liu, P., Li, H., Li, S., & Leung, K.-S. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2910-6 · Cited by 175
Manica, M., Oskooei, A., Born, J., Subramanian, V., Sáez-Rodríguez, J., & Martínez, M. R. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00520 · Cited by 163
Ten things we have to do to achieve precision medicine
Kohane, I. S. (2015) · Science · doi:10.1126/science.aab1328 · Cited by 160
Dong, Z., Zhang, N., Li, C., Wang, H., Fang, Y., Wang, J., & Zheng, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1492-6 · Cited by 151
A novel heterogeneous network-based method for drug response prediction in cancer cell lines
Zhang, F., Wang, M., Xi, J., Yang, J., & Li, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-21622-4 · Cited by 124
Chromatin accessibility prediction via a hybrid deep convolutional neural network
Liu, Q., Xia, F., Yin, Q., & Jiang, R. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx679 · Cited by 102
Self-citationPharmacogenetics: a general review on progress to date
Daly, A. K. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx035 · Cited by 92
Health: Make precision medicine work for cancer care
Rubin, M. A. (2015) · Nature · doi:10.1038/520290a · Cited by 77
Liu, H., Zhao, Y. F., Zhang, L., & Chen, X. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.011 · Cited by 75
Lioni, M., Noma, K., Snyder, A. R., Klein–Szanto, A. J., Diehl, J. A., Rustgi, A. K., Herlyn, M., & Smalley, K. S. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0391 · Cited by 69
A link prediction approach to cancer drug sensitivity prediction
Turki, T., & Wei, Z. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0463-8 · Cited by 59
Dong, W. G., Liu, C., Zheng, X., & Li, Y. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2608-9 · Cited by 56
Plasma biguanide levels are correlated with metabolic effects in diabetic patients
Marchetti, P., Benzi, L., Cecchetti, P., GIANNARELLI, R., Boni, C. D., Ciociaro, D., Ciccarone, A. M., Cianni, G. D., Zappella, A., & Navalesi, R. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.55 · Cited by 31
Cited by
Integration strategies of multi-omics data for machine learning analysis
Picard, M., Scott-Boyer, M.-P., Bodein, A., Périn, O., & Droit, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.06.030 · Cited by 696
Large-scale foundation model on single-cell transcriptomics
Hao, M., Gong, J., Zeng, X., Liu, C., Guo, Y., Cheng, X., Wang, T., Ma, J., Zhang, X., & Song, L. (2024) · Nature Methods · doi:10.1038/s41592-024-02305-7 · Cited by 628
Graph Neural Networks and Their Current Applications in Bioinformatics
Zhang, X.-M., Liang, L., Liu, L., & Tang, M.-J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.690049 · Cited by 397
Large Scale Foundation Model on Single-cell Transcriptomics
Hao, M., Gong, J., Zeng, X., Liu, C., Guo, Y., Cheng, X., Wang, T., Ma, J., Song, L., & Zhang, X. (2023) · doi:10.1101/2023.05.29.542705 · Cited by 639
DTSyn: a dual-transformer-based neural network to predict synergistic drug combinations
Hu, J., Gao, J., Fang, X., Liu, Z., Wang, F., Huang, W., Wu, H., & Zhao, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac302 · Cited by 65
Metadata
- Authors
- Liu, Q., Hu, Z., Jiang, R., & Zhou, M.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12
- Volume
- 36
- Issue
- Supplement_2
- Pages
- i911-i918
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W3116278528
- Cited by
- 263
- References
- 37
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.